<- Go home

Added to YB: 2021-04-10

Pitch date: 2021-04-10

FBRX:US [bullish]

Forte Biosciences, Inc.

-92.25%

current return

Author Info

No bio for this author

Company Info

Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases.

Market Cap

$1.9B

Pitch Price

$993.75

Price Target

N/A

Dividend

N/A

EV/EBITDA

-18.38

P/E

-16.94

EV/Sales

N/A

Sector

Biotechnology

Category

N/A

Show full summary:
Forte Biosciences Inc. FBRX:US

A summary for this pitch has not been created yet.

Read full article (0 min)